BusinessUnited States1 sourcesNeutral

FDA delay cited in closure of biotech studying autoimmune hepatitis

By the time FDA agreed to meet with Kezar Life Sciences it was in the process of closing. The chain of events fits a pattern of FDA volatility recently.

statnews.com

via statnews.com

April 6, 2026 | 8:35 AM UTCUpdated 2h ago

Share Read original

Read the full article at statnews.com →

FDA delay cited in closure of biotech studying autoimmune hepatitis

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

statnews.com

GNewsUS

Comments

0 comments

Be respectful and constructive.

Loading comments...

US Retirement Age Is Changing: FIRE Movement, Americans Working Longer

Business

Mass. cannabis reforms approved by legislative committee

Bryan Hecht-2h ago-1 sources

Business

Drone Incursions Over U.S. Bases Raise Security Concerns As Iran Tensions Escalate

Merin Rebecca Thomas-2h ago-1 sources

Business

Why FuboTV Stock Popped Today

Joe Tenebruso-3h ago-1 sources

FDA delay cited in closure of biotech studying autoimmune hepatitis

Source Verification

Comments

US Retirement Age Is Changing: FIRE Movement, Americans Working Longer

Pixel 8 Pro owners are literally icing their phones to fix broken Wi-Fi

Related Articles

Mass. cannabis reforms approved by legislative committee

Drone Incursions Over U.S. Bases Raise Security Concerns As Iran Tensions Escalate

Why FuboTV Stock Popped Today